A recent study published in the journal 'Clinical Gastroenterology and Hepatology' suggests that daily coffee consumption may reduce the risk of developing serious liver diseases, including liver cancer, and lower the likelihood of death from these conditions. The research followed over 354,000 people for more than a decade and found that regular coffee drinkers had significantly lower risks of cirrhosis, hepatocellular carcinoma, and liver-related mortality. The protective effect increased with higher coffee intake, with those drinking five or more cups daily showing up to a 47% reduced risk of liver cancer and a 42% lower risk of liver-related death. The lead researcher, Dr. Hyunseok Kim, noted that benefits were observed even among decaf drinkers, suggesting antioxidants rather than caffeine might be responsible. However, adding sugar or sweeteners to coffee was associated with slightly less benefit and higher levels of inflammatory markers.
Bias read (Center): The article presents scientific findings without overt ideological framing. It reports on medical research conducted by health professionals and does not take a stance on political issues, social policies, or cultural values. The focus remains on health outcomes and medical conclusions, making it ap
Why factuality (85): The article reports on a study published in the journal 'Clinical Gastroenterology and Hepatology' which followed over 354,000 people for more than a decade. It provides specific risk reductions associated with coffee consumption and cites the lead author, Dr. Hyunseok Kim. The information aligns wi
Why objectivity (78): The article presents the study findings in a neutral manner, explaining the statistical associations between coffee consumption and reduced risks. However, it uses somewhat emotive language like 'puede reducir el riesgo' (can reduce the risk) and ends with an incomplete quote from the lead author, w





